Principles of treatment of bacterial meningitis.
D000617:Aminoglycosides / Q000134:cerebrospinal fluid / Q000627:therapeutic use; D000667:Ampicillin / Q000134:cerebrospinal fluid / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000134:cerebrospinal fluid / Q000378:metabolism / Q000627:therapeutic use*; D001424:Bacterial Infections / Q000188:drug therapy*; D001812:Blood-Brain Barrier; D002511:Cephalosporins / Q000134:cerebrospinal fluid / Q000627:therapeutic use; D002701:Chloramphenicol / Q000134:cerebrospinal fluid / Q000627:therapeutic use; D004338:Drug Combinations / Q000134:cerebrospinal fluid / Q000627:therapeutic use; D006801:Humans; D008581:Meningitis / Q000188:drug therapy*; D008583:Meningitis, Haemophilus / Q000188:drug therapy; D008585:Meningitis, Meningococcal / Q000188:drug therapy; D008586:Meningitis, Pneumococcal / Q000188:drug therapy; D010406:Penicillins / Q000134:cerebrospinal fluid / Q000627:therapeutic use; D013420:Sulfamethoxazole / Q000134:cerebrospinal fluid / Q000627:therapeutic use; D014295:Trimethoprim / Q000134:cerebrospinal fluid / Q000627:therapeutic use; D015662:Trimethoprim, Sulfamethoxazole Drug Combination
D000617:Aminoglycosides; D000900:Anti-Bacterial Agents; D002511:Cephalosporins; D004338:Drug Combinations; D010406:Penicillins; D002701:Chloramphenicol; D000667:Ampicillin; D015662:Trimethoprim, Sulfamethoxazole Drug Combination; D014295:Trimethoprim; D013420:Sulfamethoxazole